Molecular Cytogenetics Market- Global Opportunity Analysis And Industry Forecast (2017-2022)
Global
Molecular Cytogenetics Market Size by Technique
(Fluorescence In Situ Hybridization, Comparative Genomic Hybridization, In situ
Hybridization, Karyotyping, and Banding Techniques), by Product (Instruments,
Kits and Reagents, Software, Services, and Consumables/Accessories ), by
Application (Oncology, Genetic Disorders, Personalized Medicines, and others),
by End User (Pharmaceuticals and Biotechnology Companies, Clinical and
Diagnostic Laboratories, and Academic Institutes) Global Opportunity Analysis
and Industry Forecasts To 2022.
Global molecular
cytogenetics market is expected to reach USD 2,266.4 million by 2022, supported
by a CAGR of 11% during the forecast period of 2017 to 2022. The global
molecular cytogenetics market is mainly driven by increasing focus on
preventive healthcare measures, increasing genetic abnormalities, rising aging
population and subsequent increase in various chronic diseases, growing need to
reduce mounting healthcare cost, and increasing focus on clinical and research
diagnosis. Moreover, increasing focus on targeted based therapies and growing
predictive and presymptomatic genetic testing further provides significant
opportunities in this market. However, lack of awareness about emerging
diagnosis technologies, high cost of diagnosis, unfavourable reimbursement
scenario, and technical limitations and complexities of the equipment inhibits
the growth of the market to some extent.
Browse
in-depth Report on //www.meticulousresearch.com/product/molecular-cytogenetics-market/
The global
molecular cytogenetics market is mainly segmented by technique (fluorescence in
situ hybridization, comparative genomic hybridization, in situ hybridization,
karyotyping, and banding techniques), by product (instruments, kits and
reagents, software, services, and consumable/accessories ), by application
(oncology, genetic disorders, personalized medicines, and other), and by end
user (pharmaceuticals and biotechnological companies, clinical and diagnostic
laboratories, and academic institutes). The comparative genome hybridization is
further classified into an array based CGH and matrix based CGH, whereas, the
karyotyping market is further segmented into Spectral Karyotyping and virtual
karyotyping. Banding techniques are further classified into G banding, R
banding, C banding, Q banding, and T banding.
Request-Sample-Report https://www.meticulousresearch.com/request-sample-report/?cp_id=3067
The leading companies
have employed various strategies to expand their product and application
offerings, global footprint, and augment their market share. The key strategies
followed by most companies in the global molecular cytogenetics market were new
product developments, acquisitions, and expansions. The key players in the
global molecular cytogenetics market are Thermo Fisher Scientific, Abbott
Laboratories, Agilent Technologies, PerkinElmer, Bio-Rad Laboratories, Applied
Spectral Imaging, Quest Diagnostics, Roche Diagnostics, Danaher Corporation,
Illumina, and Oxford Gene Technology.
About Meticulous Research®
Meticulous Research® is founded in 2010 and incorporated as
Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under
the Companies Act, 1956. Since its incorporation, the company has become the
leading provider of premium market intelligence in North America, Europe,
Asia-Pacific, Latin America, and Middle East & Africa
Contact
Us:
Viren Shrivastava
Viren Shrivastava
AVP-
Global Sales and Marketing
Meticulous
Research®
Tel:
+1-646-781-8004
Email:
viren@meticulousresearch.com
Comments
Post a Comment